Research on Malignancies in AIDS and Acquired Immune Suppression
PA-04-157
Application Receipt Dates: January 2,
May 1, September 1, 2005; January 2,
May 1, September 1, 2006; January 2,
May 1, September 1, 2007

The purpose of this initiative is to stimulate research that will improve our understanding of the biological basis of development and progression of cancer in the context of Human Immunodeficiency Virus (HIV) infection and Acquired Immune Deficiency Syndrome (AIDS) or acquired immune suppression not associated with HIV infection such as organ transplantation. NCI and the National Institute of Dental and Craniofacial Research seek to encourage novel approaches to discovery and preclinical development of novel therapeutic agents and biomarkers for early diagnosis and monitoring of disease progression.

This funding opportunity will use the NIH exploratory/development (R21) award mechanism and the NIH investigator-initiated research project grants (R01) award mechanism.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2260

Inquiries: Dr. Elizabeth Read-Connole, bconnole@mail.nih.gov; Dr. Sandra L. Melnick, melnicks@mail.nih.gov; Dr. Roy Wu, wur@ctep.nci.nih.gov